EIB finances Almirall’s research into new skin disease treatments
The European Investment Bank (EIB) has granted a €120 multimillion loan to Spanish pharmaceutical company Almirall under the investment plan for Europe.
The European Investment Bank (EIB) has granted a €120 multimillion loan to Spanish pharmaceutical company Almirall under the investment plan for Europe.